Literature DB >> 8600898

Ocular tumoral calcinosis. A clinicopathologic study.

F Ghanchi1, A Ramsay, S Coupland, D Barr, W R Lee.   

Abstract

Tumoral calcinosis is a rare systemic disorder characterized by para-articular ectopic soft-tissue calcification. This case report describes the ophthalmic features (palpebral conjunctival calcific nodules, the white limbal girdle of Vogt, disc drusen, and angioid streaks) in a 38-year-old Asian woman who had tumoral calcinosis associated with hyperphosphatemia. A morphologic study of the calcified nodules on the palpebral conjunctiva disclosed deposition of hydroxyapatite crystals in an extracellular matrix (deposit) containing alcianophilic mucopolysaccharides. Excision of the eyelid nodules was not followed by recurrence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600898     DOI: 10.1001/archopht.1996.01100130337022

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Bilaminar interepithelial bodies within fingerprint dystrophy-like changes in bilateral iridocorneal endothelial syndrome.

Authors:  C Auw-Haedrich; U Sengler; W R Lee
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

2.  Calcinosis cutis at the tarsus of the upper eyelid.

Authors:  Ikhyun Jun; Sung Eun Kim; Sang Yeul Lee; Gi Jeong Kim; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2011-11-22

3.  An ocular presentation of familial tumoral calcinosis.

Authors:  Emer McGrath; Fiona Harney; Frank Kinsella
Journal:  BMJ Case Rep       Date:  2010-09-20

4.  Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis.

Authors:  Shoji Ichikawa; Anthony M Austin; Amie K Gray; Matthew R Allen; Michael J Econs
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

5.  Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations.

Authors:  Shoji Ichikawa; Geneviève Baujat; Aksel Seyahi; Anastasia G Garoufali; Erik A Imel; Leah R Padgett; Anthony M Austin; Andrea H Sorenson; Zagorka Pejin; Vicken Topouchian; Pierre Quartier; Valerie Cormier-Daire; Michele Dechaux; Fotini Ch Malandrinou; Panagiotis N Singhellakis; Martine Le Merrer; Michael J Econs
Journal:  Am J Med Genet A       Date:  2010-04       Impact factor: 2.802

Review 6.  Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.

Authors:  M Chakhtoura; M S Ramnitz; N Khoury; G Nemer; N Shabb; A Abchee; A Berberi; M Hourani; M Collins; S Ichikawa; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2018-06-20       Impact factor: 4.507

7.  Phosphatonins: new hormones involved in numerous inherited bone disorders.

Authors:  Laura Masi
Journal:  Clin Cases Miner Bone Metab       Date:  2011-09

8.  Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Gui Shuang Ying; Samuel Houston; Tamara Isakova; Lisa Nessel; Akinlolu Ojo; Alan Go; Jim Lash; John Kusek; Juan Grunwald; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2015-04-24       Impact factor: 5.992

9.  Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification.

Authors:  Eli Sprecher
Journal:  J Invest Dermatol       Date:  2009-10-29       Impact factor: 8.551

Review 10.  Optic disk drusen in children.

Authors:  Melinda Y Chang; Stacy L Pineles
Journal:  Surv Ophthalmol       Date:  2016-03-29       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.